Paravertebral Block for Percutaneous Radiofrequency Ablation of Liver Lesions
TPVB
Evaluation of the Analgesic Efficacy of the Ultrasound Guided Thoracic Paravertebral Block for Percutaneous Radiofrequency Ablation of Liver Lesions
1 other identifier
observational
40
1 country
1
Brief Summary
Percutaneous radiofrequency ablation of liver lesions causes patients acute pain during and after the procedure. During the procedure patients need deep sedation and cannot be collaborative. Furthermore post-operative analgesia is necessary. The aim of this study is to evaluate if the ultrasound-guided paravertebral block (TPVB)with a single injection can provide anesthesia and post-operative analgesia in these patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2012
CompletedFirst Submitted
Initial submission to the registry
March 8, 2013
CompletedFirst Posted
Study publicly available on registry
March 18, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2022
CompletedAugust 23, 2024
August 1, 2024
1 year
March 8, 2013
August 22, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Intensity of postoperative pain after radiofrequency ablation of liver lesion
Intensity of postoperative pain after radiofrequency ablation of liver lesion is evaluated in both groups using VRS of pain at rest and in movement after 3-6-12-24 hours from procedure.
first 24 post-operative hours
Secondary Outcomes (2)
Incidence of complications
From procedure to 24 hours
Consumption of post-operative opioid
Within 24 post-operative hours
Other Outcomes (1)
Satisfaction of patient and of the operator
From the procedure to 24 hours later.
Study Arms (2)
Thoracic paravertebral block (TPVB)
Twenty patients receiving thoracic paravertebral block at level of T7, before the interventistic procedure.
Deep Sedation (DS)
Twenty patients receiving local and intravenous anesthesia during the procedure.
Eligibility Criteria
In this study 40 patients undergoing elective procedure of radiofrequency ablation of liver lesions are enrolled after written informed consent is obtained.
You may qualify if:
- written consent ASA I-III
You may not qualify if:
- allergy to local anesthetic infection in the site of planned injection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Campus Bio-Medico
Rome, Italy/RM, 00121, Italy
Related Publications (2)
Hara K, Sakura S, Nomura T, Saito Y. Ultrasound guided thoracic paravertebral block in breast surgery. Anaesthesia. 2009 Feb;64(2):223-5. doi: 10.1111/j.1365-2044.2008.05843.x. No abstract available.
PMID: 19143711BACKGROUNDRenes SH, Bruhn J, Gielen MJ, Scheffer GJ, van Geffen GJ. In-plane ultrasound-guided thoracic paravertebral block: a preliminary report of 36 cases with radiologic confirmation of catheter position. Reg Anesth Pain Med. 2010 Mar-Apr;35(2):212-6. doi: 10.1097/aap.0b013e3181c75a8b.
PMID: 20301827BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Massimiliano Carassiti, MD
Campus Bio Medico
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
March 8, 2013
First Posted
March 18, 2013
Study Start
December 1, 2012
Primary Completion
December 1, 2013
Study Completion
September 1, 2022
Last Updated
August 23, 2024
Record last verified: 2024-08